Fundamental analysis · SEC EDGAR · as of 31/03/2026

Fundamental analysis of Mckesson Corp

MCK · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Fundamental quality

DEMANDING

52

out of 100

Breakdown by area

I.GrowthEPS: 10.2% · Revenue: 13.4%
65
II.ProfitabilityNet margin: 1.2% · ROE: -219.2%
26
III.Financial healthNet debt/EBITDA: 0.66x · FCF: 1.4%
66

Source: SEC EDGAR · as of 31/03/2026

Reading the numbers

On average over recent years, earnings per share grew 10.2% a year and revenue advanced 13.4% a year.

On profitability, Mckesson Corp shows a net margin of 1.2%, a gross margin of 3.6%, an ROE of -219.2%.

Its financial health shows net debt of 0.66 times its EBITDA and a free cash flow margin of 1.4%.

Adding up growth, profitability and financial strength, the traffic light gives MCK a fundamental quality of 52 out of 100. To also know whether it's cheap or expensive, the price is missing: enter it in the tool and you'll get the valuation verdict (P/E against its sector).

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Mckesson Corp cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Mckesson Corp?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →